Pacira BioSciences, Inc.
PCRXPharmaceutical Preparations · SIC 2834 · CIK 0001396814
Revenue FY2025
$726.0M
Net Income
$7.0M
EPS (Basic)
$0.16
Net Margin
1.0%
ROE
1.0%
Total Equity
$693.0M
Shares Out
40M
Pacira BioSciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 1 fund in our universe
FundPosition Value% of AUMQoQ ChgWeight
Renaissance Technologies
Renaissance Technologies
$44.0M
0.0%
(5.0%)
Insider Transactions
Reading stored insider transactions…